Inventor

Mitchell A. deLong

Inventor

Chapel Hill, NC, US

Overview

1999–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 79 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%

C07DHeterocyclic compounds22%

A61KPreparations for medical, dental or toiletry purposes18%

C07CAcyclic or carbocyclic compounds17%

A61QSpecific use of cosmetics or similar toiletry preparations7%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%

C07HSugars1%

Y02PClimate change mitigation technologies in the production or processing of goods1%

C07BGeneral methods of organic chemistry1%

C07JSteroids0%

PatentTitleYear

11,117,869Compounds, compositions and methods for treatment of myopia2021 11,059,789Isoquinoline-steroid conjugates and uses thereof2021 11,028,081Dual mechanism inhibitors for the treatment of disease2021 11,021,456Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds2021 11,020,385Combination therapy2021 10,899,7146-aminoisoquinoline compounds2021 10,882,840Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds2021 10,858,339Aryl cyclopropyl-amino-isoquinolinyl amide compounds2020 10,654,844Dual mechanism inhibitors for the treatment of disease2020 10,588,901Combination therapy2020 10,568,878Combination therapy2020 10,550,087Process for the preparation of kinase inhibitors and intermediates thereof2020 10,532,993Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds2020 10,472,3276-aminoisoquinoline compounds2019 10,316,029Dual mechanism inhibitors for the treatment of disease2019 10,174,017Dual mechanism inhibitors for the treatment of disease2019 10,159,634Compositions and methods for inhibiting hair growth2018 10,112,920Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds2018 9,993,470Combination therapy2018 9,963,432Beta-amino-isoquinolinyl amide compounds2018 9,951,059Dual mechanism inhibitors for the treatment of disease2018 9,931,336Combination therapy2018 9,890,123'6-aminoisoquinoline compounds'2018 9,884,840'Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds'2018 9,877,908'Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives'2018 9,849,122Combination therapy2017 9,840,468'Methods for the preparation of 6-aminoisoquinoline'2017 9,707,169'Compositions and methods for inhibiting hair growth'2017 9,708,287'Chiral compounds, compositions, products and methods employing same'2017 9,675,539'Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives'2017 9,655,833'Compositions and methods for inhibiting hair growth'2017 9,643,927'Process for the preparation of kinase inhibitors and intermediates thereof'2017 9,579,270'Compositions and methods for treating hair loss using non-naturally occurring prostaglandins'2017 9,512,101'Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds'2016 9,415,043'Combination therapy'2016 9,365,518'6-aminoisoquinoline compounds'2016 9,346,837'Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives'2016 9,180,080'Chiral compounds, compositions, products and methods employing same'2015 9,096,569'Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds'2015 8,921,392'6-aminoisoquinoline compounds'2014 8,906,962'Compositions and methods for treating hair loss using non-naturally occurring prostaglandins'2014 8,871,757'6-and 7-amino isoquinoline compounds and methods for making and using the same'2014 8,759,388'Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds'2014 8,722,739'Amino acid salts of prostaglandins'2014 8,716,310'Dual mechanism inhibitors for the treatment of disease'2014 8,642,644'Ophthamological drugs'2014 8,623,918'Amino acid salts of prostaglandins'2014 8,618,086'Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins'2013 8,541,466'Compositions and methods for treating hair loss using non-naturally occurring prostaglandins'2013 8,470,882'Amino acid salts of prostaglandins'2013 8,455,647'6-aminoisoquinoline compounds'2013 8,455,514'6-and 7-amino isoquinoline compounds and methods for making and using the same'2013 8,455,513'6-aminoisoquinoline compounds'2013 8,450,344'Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds'2013 8,394,826'Dual mechanism inhibitors for the treatment of disease'2013 8,357,699'6-aminoisoquinoline compounds'2013 RE043372'C16 unsaturated FP-selective prostaglandins analogs'2012 8,153,656'Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds'2012 8,153,654'6-and 7-amino isoquinoline compounds and methods for making and using the same'2012 8,034,943'6-aminoisoquinoline compounds'2011 7,671,205'6-aminoisoquinoline compounds'2010 7,470,787'Isoquinoline compounds'2008 7,407,987'Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins'2008 7,388,029'Compositions and methods for treating hair loss using non-naturally occurring prostaglandins'2008 7,115,659'Method of treating a condition by administering a prostaglandin derivative'2006 7,074,942'2-decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use'2006 6,894,175'2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use'2005 6,586,463'C16 unsaturated FP-selective prostaglandins analogs'2003 6,537,527'Skin lightening compositions'2003 6,451,859'C16 unsaturated FP-selective prostaglandins analogs'2002 6,444,840'C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists'2002 6,410,780'C11 oxymyl and hydroxylamino prostaglandins useful as medicaments'2002 6,372,730'2-decarboxy-2-phosphinico Prostaglandin F analogs'2002 6,156,799'Method of increasing bone volume using non-naturally-occurring FP selective agonists'2000 6,107,338'Aromatic C.sub.16 -C.sub.20 -substituted tetrahydro prostaglandins useful as FP agonists'2000 6,068,834'Skin lightening compositions'2000 6,066,751'Process for making epoxide intermediates'2000 6,048,895'Aromatic C16-C20 substituted tetrahydro prostaglandins useful as FP agonists'2000 5,977,173'Aromatic C.sub.16 -C.sub.20 -substituted tetrahydro prostaglandins useful as FP agonists'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999Based in Mason, OH, US· patent location history

2000–2006Patents assigned to PROCTER & GAMBLE (13)· patent assignee history

2000–2008Based in West Chester, OH, US· patent location history

2008–2021Patents assigned to AERIE PHARMACEUTICALS INC (43)· patent assignee history

2008–2018Patents assigned to UNIV DUKE (11)· patent assignee history

2008–2014Based in Raleigh, NC, US· patent location history

2011–2021Based in Chapel Hill, NC, US· patent location history

2013–2018Patents assigned to DELONG MITCHELL A (12)· patent assignee history

2013–2014Patents assigned to STURDIVANT JILL MARIE (10)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
AERIE PHARMACEUTICALS INC	43	2008–2021
PROCTER & GAMBLE	13	2000–2006
DELONG MITCHELL Aself	12	2013–2018
UNIV DUKE	11	2008–2018
STURDIVANT JILL MARIE	10	2013–2014

Locations

Location	Patents	Span
Chapel Hill, NC, US	48	2011–2021
Raleigh, NC, US	15	2008–2014
West Chester, OH, US	15	2000–2008
Mason, OH, US	1	1999